华海药业：卡络磺钠注射液获得药品注册证书

Core Viewpoint - Huahai Pharmaceutical has received approval from the National Medical Products Administration for the marketing of Carbetocin Injection, which is indicated for various bleeding disorders in the urinary system, upper digestive tract, respiratory tract, and obstetrics [1] Group 1 - The approved product, Carbetocin Injection, is effective for treating bleeding diseases, particularly in the urinary system [1] - The injection can also be used for the prevention and treatment of surgical bleeding [1]